V012-5037 Screening compound: 2-[4-(2-fluorophenyl)-1-(4-methoxyphenyl)-7-oxo-3-phenyl-1,4,6,7-tetrahydro-8H-pyrazolo[3,4-e][1,4]thiazepin-8-yl]-N-phenylacetamide

V012-5037 Screening compound: 2-[4-(2-fluorophenyl)-1-(4-methoxyphenyl)-7-oxo-3-phenyl-1,4,6,7-tetrahydro-8H-pyrazolo[3,4-e][1,4]thiazepin-8-yl]-N-phenylacetamide
V012-5037 Screening compound: 2-[4-(2-fluorophenyl)-1-(4-methoxyphenyl)-7-oxo-3-phenyl-1,4,6,7-tetrahydro-8H-pyrazolo[3,4-e][1,4]thiazepin-8-yl]-N-phenylacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V012-5037
2-[4-(2-fluorophenyl)-1-(4-methoxyphenyl)-7-oxo-3-phenyl-1,4,6,7-tetrahydro-8H-pyrazolo[3,4-e][1,4]thiazepin-8-yl]-N-phenylacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V012-5037

Molecular Formula

C33H27FN4O3S (C33 H27 FN4 O3 S)

Compound Name

2-[4-(2-fluorophenyl)-1-(4-methoxyphenyl)-7-oxo-3-phenyl-1,4,6,7-tetrahydro-8H-pyrazolo[3,4-e][1,4]thiazepin-8-yl]-N-phenylacetamide

IUPAC name

2-[4-(2-fluorophenyl)-1-(4-methoxyphenyl)-7-oxo-3-phenyl-1H4H6H7H8H-pyrazolo[34-e][14]thiazepin-8-yl]-N-phenylacetamide

SMILES

COc(cc1)ccc1-n(c(N1CC(Nc2ccccc2)=O)c2C(c(cccc3)c3F)SCC1=O)nc2-c1ccccc1

InChI

InChI=1S/C33H27FN4O3S/c1-41-25-18-16-24(17-19-25)38-33-30(31(36-38)22-10-4-2-5-11-22)32(26-14-8-9-15-27(26)34)42-21-29(40)37(33)20-28(39)35-23-12-6-3-7-13-23/h2-19,32H,20-21H2,1H3,(H,35,39)/t32-/m1/s1

InChI Key

MCKZGLSOODXTOS-JGCGQSQUSA-N

MDL Number (MFCD)

MFCD19789059

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

578.67

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

6.445

Distribution Coefficient, logD

6.445

Water Solubility, LogSw

-5.72

Polar Surface Area

60.718

Acid Dissociation Constant (pKa)

12.65

Base Dissociation Constant (pKb)

1.83

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

12.12

V012-5037 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Included in 1.7M Stock Database

References: we are preparing a list of scientific research reports with V012-5037 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V012-5037?
Check Price and Availability of V012-5037, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V012-5037 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V012-5037
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V012-5037
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V012-5037 available by request